Cat.#: ACPP-1322
| Despition | TRPM8 Blocking Peptide for Immunocompeition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1303 | Human Stratifin Protein (AC1303) | 5 µg | inquiry |
| ACPP-1348 | Presenilin 1 Blocking Peptide (AC1348) | 250 µg | inquiry |
| ACPP-1772 | Human CALB2 Protein (AC1772) | 5 µg | inquiry |
| ACPP-1844 | Human GCLM Protein (AC1844) | 5 µg | inquiry |
| ACPP-1335 | Nicotinic Acetylcholine Receptor alpha 7 Blocking Peptide (AC1335) | 250 µg | inquiry |
| ACPP-1819 | Human TRH Protein (AC1819) | 100 mg | inquiry |
| ACPP-1377 | Human KCNMB3 Protein (AC1377) | 5 µg | inquiry |
| ACPP-1782 | TPX E.coli (AC1782) | 5 µg | inquiry |
| ACPP-1417 | Human STMN3 Protein (AC1417) | 2 µg | inquiry |
| ACPP-1040 | Recombinant Mouse Eph Receptor A2 Protein (6×His Tag) (AC1040) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.